86.22.Z - Specialist medical practice
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
68.20.Z - Rental and management of own or leased real estate
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.90.E - Healthcare
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2 | 0 | 2,7 | -∞ |
EBITDA | 2,5 | 0 | 3,9 | -∞ |
Short time liabilities | 1 | 0,4 | 0,9 | 121 |
Equity capital | 4,9 | 6,6 | 9,1 | 36,9 |
Operating profit (EBIT) | 2 | 0 | 2,8 | -∞ |
Assets | 6,1 | 9 | 11,7 | 30,3 |
Net profit (loss) | 1,8 | 0 | 2,5 | -∞ |
Cash | 0,1 | 3,6 | 4,2 | 15,4 |
Liabilities and provisions for liabilities | 1,3 | 2,4 | 2,6 | 11,7 |
Net income from sale | 4,9 | 0 | 8,7 | -∞ |
Working assets | 3,5 | 4,9 | 4,9 | 0,5 |
Depreciation | 0,5 | 0 | 1 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 37,9 | 0 | 26,9 | 26,9 |
Equity capital to total assets | 79,4 | 73,8 | 77,5 | 3,7 |
Gross profit margin | 40,3 | 31 | -9,3 | |
EBITDA Margin | 50,4 | 44,4 | -6 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 73 | 2 147 483 648 | 40 | -2 147 483 608 |
Current financial liquidity indicator | 3.480748414993286 | 11.195015907287598 | 5.104543685913086 | -6,1 |
Net dept to EBITDA | 0.06286226212978363 | -0.6428220272064209 | -0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane